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ABSTRACT 
Present study involves the development of a polyherbal formulation by using four different herbs i.e. Chirata (Swertia chiratia), Haldi (Curcuma 
longa), Neem (Azadirachta indica), Gudmar (Gymnema sylvestre), Ashwagandha (Withania somnifera), Gokharu (Pedalium murex), Methi 
(Trigonella foenum-graecum), Jammun (Syzygium cumini), relating to antidiabetic activity. Freshly collected and authenticated herbs were 
characterized by studying its morphological and pharmacognostic character. Antidiabetic and antioxidant activity of the formulation was 
determined by in vitro haemoglobin glycosylation assay and H2O2 radical scavenging method respectively. In the above study it was found that 
ethanolic extract of polyherbal formulation possess promising antidiabetic and antioxidant activity which can be consider for further biological 
investigation. 
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INTRODUCTION 
The American Diabetes Association classifies diabetes 
mellitus into four types. Type 1 also known as insulin 
dependent diabetes mellitus (IDDM) in which genetic 
deficiency in insulin production as a result of allergic 
reactions which destroy the pancreatic beta cells. Type 2 also 
known as non-insulin dependent diabetes mellitus (NIDDM) 
is combined resistance to insulin-action and insulin-
secretory response. Type 3 also known as gestational 
diabetes causes carbohydrate intolerance with first 
recognition during pregnancy and type 4 (genetic defect- or 
medication-induced diabetes). Among all the types NIDDM 
accounts for approximately 90% of the diabetes cases 
globally1-2. Ayurvedic system of medicine is as old as human 
civilization. Herbal plants produce a diverse range of 
bioactive molecules, making them a rich source of different 
types of medicines. The human body has a complex system of 
natural enzymatic and non-enzymatic antioxidant defenses 
which counteract the harmful effects of free radicals and 
other oxidants3. Study suggest that polyherbal formulations 
have promising antioxidant properties in term of H2O2 
radical scavenging activity and validates their synergistic 
effect by having an improved activity in most of the 
formulations4. As such developing a polyherbal formulation 
will definitely produce synergistic effect as needed 
comparable to standard drugs that are available in market all 
over the world. In the traditional system of Ayurveda, 
polyherbal formulations are used as drug of choice rather 
than individual plant extract. Various herbal formulations 
such as DIAMED, COAGENT and HYPONID are known for 
their antidiabetic effect. However, these formulations cannot 
be said ideal in the treatment of diabetes 5-6. The polyherbal 
formulation, which has a combination of medicinal herbs 
such as Chirata (Swertia chiratia), Haldi (Curcuma longa), 
Neem (Azadirachta indica), Gudmar (Gymnema sylvestre), 
Ashwagandha (Withania somnifera), Gokharu (Pedalium 
murex), Methi (Trigonella foenum-graecum), Jammun 
(Syzygium cumini), can serve as antidiabetic agent.  
Chirata leaves, Haldi rhizomes, Neem seeds, Gudmar leaves, 
Ashwagandha stem, Gokharu fruits, Methi seeds, Jammun 
seeds are used in traditional medicine in the treatment of 
chronic cases of high blood pressure, obesity, diabetes, 
various digestive ailments, as well as geriatric and 
antiarteriosclerosis remedies7-8. Literatures revealed that 
the selected eight herbs have antioxidant activity. Hence an 
attempt was made to formulate a polyherbal formulation, 
and to evaluate its in vitro antioxidant activity9. Aerobic 
respiration, stimulated polymorphonuclear leukocytes, 
macrophages and perioxisomes causes formation of reactive 
oxygen species (ROSs). These appear to be the main 
endogenous sources of most of the oxidants produced by 
cells. Exogenous sources of free radicals include tobacco 
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smoke, ionizing radiation, certain pollutants, organic 
solvents and pesticides. Life threatening diseases like cancer, 
emphysema, cirrhosis, atherosclerosis, and arthritis can be 
correlated with oxidative damage10. Numerous vitamins, 
minerals and other phytochemicals may act as antioxidant to 
protect the damage caused by ROS11-12. A non-enzymatic 
reaction between free amino groups of proteins and 
reducing sugars is known as glycation. The increased 
glycation is nothing but additional binding of glucose to 
hemoglobin which may leads to formation of reactive oxygen 
species (ROS). Such accelerated haemoglobin glycation can 
also cause pathogenic conditions like angiopathy, 
nephropathy and neuropathy in diabetic patients. When 
oxidation occurs in glycation process, it leads to 
glycoxidation and formation of advanced glycation end 
products13. 
Impaired glucose metabolism in diabetes is associated with 
increase free radical generation (oxidative stress) causes 
serious cell damage leading to a variety of human diseases 
like Alzheimer’s disease, Parkinson’s disease, 
atherosclerosis, cancer, arthritis, immunological 
incompetence, and neurodegenerative disorders, etc14. 
Antioxidants are intimately involved in the prevention of 
cellular damage - the common pathway for cancer, aging, and 
a variety of diseases15-16.  The purpose of the present study 
was to investigate the in-vitro antioxidant and antidiabetic 
potential of polyherbal formulation. 
MATERIALS AND METHODS  
Haemoglobin glycosylation assay 
The blood of healthy volunteers was collected in EDTA vials 
from a pathology laboratory of Ayurved Medical College 
(Shobhit University, Gangoh). Haemolysate was prepared 
based on the principle of hypotonic lysis17. Collected blood 
was washed three times with sodium chloride solution. One 
volume of red blood cells suspension was lysed with 2 
volumes of phosphate buffer and 0.5 volume of chloroform. 
The haemolysate was then centrifuged at to achieve clear 
hemoglobin solution was obtained by centrifugation of 
haemolysate at 2300 rpm for 15 min at room temperature.  
The upper layer containing haemoglobin fraction was 
separated and kept in refrigerator for use in the assay. 
Evaluation of haemoglobin glyacation was estimated by the 
method of Adisa et al18.  
1 ml of haemoglobin solution (obtained by hypotonic lysis), 
5μl of gentamycin and 100, 200, 400, 800, and 1000 µg ml-1 
of polyherbal formulation were added in test tubes. 1 ml of 
20 mM glucose in 10mM phosphate buffer of pH 7.4 was 
added to the mixture to start the reaction and the contents 
were incubated at room temperature for 72 hrs. 
Spectrophotometer at 443nm was used for estimation of 
glycated haemoglobin at the incubation interval of 24, 48 
and 72 hrs (Table 1). 
  
Table 1: Effect of polyherbal formulation on hemoglobin glycosylationat physiological glucose concentrations 
  S.No 
 
Concentration (µg ml) 
 
% Hemoglobin glycosylation inhibition 
           24 hrs     48 hrs 72 hrs 
1 100 16.36 18.43           32.72 
2 200 22.23 28.64 52.56 
3 400 24.36 36.52 66.58 
4 800 27.34 42.54 80.62 
5 1000 30.26 46.32 92.18 
 
Similarly for haemoglobin glycosylation at physiological 
glucose concentration, a mixture of 1 ml of glucose solution 
(2, 10 and 20 mg ml-1), 1 ml of haemoglobin solution, and 5μl 
of gentamycin in 20 ml of 10 mM phosphate buffer (pH 7.4) 
and 100, 200, 400, 800, and 1000 µg ml-1 of Gallic acid and 
polyherbal formulation respectively were taken in test tube. 
Contents were incubated at room temperature for a period 
of 72 hrs as an indicator of haemoglobin glycosylation. The 
assay was carried out in triplicates and percent haemoglobin 
glycosylation was calculated (Graph 1-3). 
 
 
Graph 1: The comparative effects of plant extracts on 
haemoglobin glycosylation at physiological glucose 
concentration after 24 hrs of incubation. 
 
Graph 2: The comparative effects of plant extracts on 
hemoglobin glycosylation at physiological glucose 
concentration after 48 hrs of incubation.
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Graph 3: The comparative effects of plant extracts on haemoglobin glycosylation at physiological glucose concentration 
after 72 hrs of incubation. 
 
Hydrogen peroxide assays 
The hydrogen peroxide scavenging was determined 
according to the method of Ruch et al. The absorbance value 
of the reaction mixture was recorded at 230 nm. Hydrogen 
peroxide scavenging activity was calculated using the 
equation: (1 - Absorbance of sample/ absorbance of control) 
× 100. Each experiment was carried out in triplicateand 
results averaged expressed as mean ± SD (Table 2). 
 
Table 2: H2O2 Radical Scavenging Assay 
 
Different Extract 
Concentration (µg/mL) 
50 100 200 400 800 1000 IC50 
Ascorbic Acid 60.13 71.56 79.51 82.30 83.44 83.86 9.16 
Ethanolic 48.27 54.17 58.15 59.23 60.28 62.96 11.12 
Chloroform 66.25 69.15 71.89 72.90 73.67 75.34 14.78 
Aqueous 77.16 83.20 86.72 86.84 87.83 89.17 10.23 
 
RESULTS AND DISCUSSION 
Haemoglobin glycosylation assay 
The glycosylation hemoglobin assay is essential for the 
diagnosis and management of diabetes because it provides 
the best estimate of a patient’s average blood glucose (AG) 
over the preceding 2–3 months and is the best predictor of 
disease complications. Generally the haemoglobin 
glycosylation is determined   mainly to identify the average 
glucose concentration over a prolonged period of time.  
Higher values of glycated haemoglobin indicate poor control 
of blood glucose level under diabetic condition. The in-
vitrohaemoglobin glycosylation inhibition assay showed 
considerable inhibition of glycosylation over a period of 72 
hrs as compared to gallic acid. The in vitro assays of the 
present study indicated that all the three extracts; ethanolic, 
chloroform and aqueous possess good anti diabetic activity. 
Hydrogen peroxide assays 
Oxygen free radical can begin peroxidation of lipids, which in 
turn stimulates glycation of proteins, inactivation of 
antioxidant enzymes and play a role in long term 
complication of diabetes. Regardless of the presence of well-
known antidiabetic medicines in the pharmaceutical market, 
remedies from medicinal plants are used with success to 
treat this disease possibly because they are believed to be 
less toxic and free from side effects compared to synthetic 
one. Our polyherbal formulation contains eight different 
ingredients which are known to possess antidiabetic and 
antioxidant activity. In general, H2O2 radical scavenging 
assay is widely used to evaluate the antioxidant properties of 
extracts from different plant materials. Due to their natural 
origin of the extracts, the use of natural antioxidant from 
plants does not induce side effect. The higher antioxidant 
properties in polyherbal formulation might be due to the 
properties of the plant that conferred with high amount of 
flavones, polyphenols, glycosides, bioactive active proteins, a 
volatile oil, and massive quantities of potassium19. Ethanolic 
extract showed better antioxidant property followed by 
aqueous and chloroform extract.  
CONCLUSIONS 
Findings of in-vitro glycosylation of haemoglobin and H2O2 
radical scavenging activity assay clearly indicate that 
polyherbal formulation possesses considerable antidiabetic 
and antioxidant activity. It was observed that different 
extracts of polyherbal formulation inhibited the formation of 
glycated end products. Identification and characterization of 
bioactive compounds liable for such activities along with in 
vivo investigations should be done further. Free radicals play 
an important role in the development of degenerative 
diseases like diabetes hence supplementation with 
antioxidant may overcome diabetic complications. This 
polyherbal formulation can serve Therapeutic agents in 
maintaining blood glucose levels in diabetic patients.  
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